Hrivnak Robert G.
Known title: CAO and Interim CFOCIK: 0001589130
Hrivnak Robert G.'s purchase track record
How the stock did after each of Hrivnak Robert G.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
7
of 7 since November 10, 2021
Stock higher 6 months later
43%
3 months: 57%
Median 6-month return
-3.7%
3 months: +0.1%
Beat the S&P 500
100%
median +7.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/11/2023 | OEC | $44 | +34.4% | +13.8% | +12.7% |
| 10/4/2022 | OEC | $44 | +20.5% | +74.6% | +8.2% |
| 7/1/2022 | OEC | $44 | -15.1% | +13.4% | +0.4% |
| 4/7/2022 | OEC | $44 | +5.8% | -4.4% | -16.8% |
| 1/20/2022 | OEC | $1 | -8.7% | -3.7% | -10.8% |
| 1/12/2022 | OEC | $42 | -18.1% | -16.8% | -19.6% |
| 11/10/2021 | OEC | $50K | +0.1% | -13.5% | -15.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| OEC | ▼ Sell | Tax Withholding | 153 | $4K | 4/3/2023 | View on chart |
| OEC | ▲ Buy | Grant | 152 | $0 | 4/3/2023 | View on chart |
| OEC | ▼ Sell | Tax Withholding | 38 | $986 | 4/3/2023 | View on chart |
| OEC | ▼ Sell | Open Market | 2,514 | $67K | 3/6/2023 | View on chart |
| OEC | ▲ Buy | Open Market | 2 | $44 | 1/11/2023 | View on chart |
| OEC | ▲ Buy | Grant | 2,044 | $0 | 10/27/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 3 | $44 | 10/4/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 3 | $44 | 7/1/2022 | View on chart |
| OEC | ▲ Buy | Grant | 10,000 | $0 | 5/13/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 3 | $44 | 4/7/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 0 | $1 | 1/20/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 2 | $42 | 1/12/2022 | View on chart |
| OEC | ▲ Buy | Open Market | 2,500 | $50K | 11/10/2021 | View on chart |
| OEC | ▲ Buy | Grant | 5,000 | $0 | 11/1/2021 | View on chart |
| OEC | ▲ Buy | Grant | 1,971 | $0 | 10/6/2021 | View on chart |
| OEC | ▲ Buy | Grant | 623 | $0 | 9/30/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
RBC Notes Orion's Leveraged Uranium Exposure
RBC Capital Markets highlighted that Orion S.A. offers highly leveraged exposure to US uranium. This note draws attention to the company's specific positioning in the nuclear fuel sector. The stock currently trades near its average analyst target price, with a 52-week range spanning from $4.34 to $8.64.
RBC Notes Orion's Leveraged Uranium Exposure. RBC Capital Markets highlighted that Orion S.A. offers highly leveraged exposure to US uranium. This note draws attention to the company's specific positioning in the nuclear fuel sector. The stock currently trades near its average analyst target price, with a 52-week range spanning from $4.34 to $8.64.